Medpace Q3 Earnings, Revenue Rise; Lifts 2026 Outlook

04:42 PM EDT, 10/21/2026 (MT Newswires) -- Medpace (MEDP) reported Q3 earnings late Wednesday of $4.84 per diluted share, up from $3.86 a year earlier. Analysts polled by FactSet expected $4.44. Revenue for the quarter ended Sept. 30 was $716.0 million, up from $659.9 million a year ago. Analysts expected $714.5 million. For full-year 2026, the company now expects EPS of $17.97 to $18.32 per share on revenue of $2.84 billion to $2.86 billion. It previously expected EPS of $17.25 to $17.95 per share on revenue of $2.81 billion to $2.89 billion. Analysts expect $17.61 on revenue of $2.85 billion.